Jaks, Stats and the immune system

被引:27
作者
Decker, T [1 ]
Meinke, A [1 ]
机构
[1] Vienna Bioctr, Inst Microbiol & Genet, A-1030 Vienna, Austria
基金
奥地利科学基金会;
关键词
D O I
10.1016/S0171-2985(97)80031-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Changes in gene expression are necessary for an adaptive response of cells to immunological stimuli and thus for their proper function in the concert of the immune system. Regulatory inputs usually originate from cell surface receptors and in many cases affect the transcription rates of specific genes by modulating the activity of transcription factors. The Jak-Stat signalling paradigm has received large attention by molecular immunologists because it applies to nuclear signalling by all cytokine receptors. In its simplest form it requires only two protein components downstream of the receptor: Janus family protein tyrosine kinases (Jaks) which are usually receptor-associated, and signal transducer and activator of transcription (Stat) family transcription factors which carry the receptor-generated signal to the nucleus and stimulate gene expression. Here we give a brief overview of both recent progress and open questions concerning the Jak and Stat molecules, their regulation, and the biological implications of their activity.
引用
收藏
页码:99 / 111
页数:13
相关论文
共 67 条
[1]   PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation [J].
Ali, S ;
Chen, ZJ ;
Lebrun, JJ ;
Vogel, W ;
Kharitonenkov, A ;
Kelly, PA ;
Ullrich, A .
EMBO JOURNAL, 1996, 15 (01) :135-142
[2]   INTERLEUKIN-3 SIGNALS THROUGH MULTIPLE ISOFORMS OF STAT5 [J].
AZAM, M ;
ERDJUMENTBROMAGE, H ;
KREIDER, BL ;
XIA, M ;
QUELLE, F ;
BASU, R ;
SARIS, C ;
TEMPST, P ;
IHLE, JN ;
SCHINDLER, C .
EMBO JOURNAL, 1995, 14 (07) :1402-1411
[3]   INTERLEUKIN-12 (IL-12) INDUCES TYROSINE PHOSPHORYLATION OF JAK2 AND TYK2 - DIFFERENTIAL USE OF JANUS FAMILY TYROSINE KINASES BY IL-2 AND IL-12 [J].
BACON, CM ;
MCVICAR, DW ;
ORTALDO, JR ;
REES, RC ;
O'SHEA, JJ ;
JOHNSTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :399-404
[4]   Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway [J].
Beadling, C ;
Ng, J ;
Babbage, JW ;
Cantrell, DA .
EMBO JOURNAL, 1996, 15 (08) :1902-1913
[5]   Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha [J].
Bhattacharya, S ;
Eckner, R ;
Grossman, S ;
Oldread, E ;
Arany, Z ;
DAndrea, A ;
Livingston, DM .
NATURE, 1996, 383 (6598) :344-347
[6]   STAT3 ACTIVATION BY CYTOKINES UTILIZING GP130 AND RELATED TRANSDUCERS INVOLVES A SECONDARY MODIFICATION REQUIRING AN H7-SENSITIVE KINASE [J].
BOULTON, TG ;
ZHONG, Z ;
WEN, ZL ;
DARNELL, JE ;
STAHL, N ;
YANCOPOULOS, GD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6915-6919
[7]   JAKs and STATs branch out [J].
Briscoe, J ;
Kohlhuber, F ;
Muller, M .
TRENDS IN CELL BIOLOGY, 1996, 6 (09) :336-340
[8]   Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state [J].
Briscoe, J ;
Rogers, NC ;
Witthuhn, BA ;
Watling, D ;
Harpur, AG ;
Wilks, A ;
Stark, GR ;
Ihle, JN ;
Kerr, IM .
EMBO JOURNAL, 1996, 15 (04) :799-809
[9]   Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma [J].
Bromberg, JF ;
Horvath, CM ;
Wen, ZL ;
Schreiber, RD ;
Darnell, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7673-7678
[10]  
Cho SS, 1996, J IMMUNOL, V157, P4781